Stomach cancer combo study halted early

NCT ID NCT05251948

Terminated Disease control Sponsor: Hoffmann-La Roche Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tested several drug combinations in 40 people with advanced stomach or gastroesophageal junction cancer that had not been treated before. The goal was to see which combinations shrank tumors. The study was terminated early, so results are limited.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ADVANCED GASTRIC CARCINOMA are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

gastric carcinoma gastroesophageal cancer gastroesophageal junction adenocarcinoma

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

GASTRIC AND GASTROESOPHAGEAL JUNCTION CARCINOMA

Contacts and locations

Locations

Affiliated Hopsital of Jining Medical University

Jining, 272000, China
First Affiliated Hospital of Gannan Medical University

Ganzhou, 341000, China
Nan Tong Tumor Hospital

Nantong, 226361, China
Nanjing Drum Tower Hospital, the Affiliated Hospital of Nanjing University Medical School

Nanjing, 210008, China
Shanxi Province Cancer Hospital

Taiyuan, 030013, China
Sir Run Run Shaw Hospital, School of Medicine, Zhejiang University

Hangzhou, 310016, China
The First Affiliated Hospital of Xian Jiao Tong University

Xi'an, 710061, China
The First Affiliated Hospital, Zhejiang University

Hangzhou, 310003, China
The General Hospital of People?s Liberation Army (301 Hospital)

Beijing, 100853, China
The Second Affiliated Hospital of Anhui Medical University

Hefei, 230601, China
the First Hospital of Jilin University

Changchun, 130021, China

More trials for these conditions

Other studies related to the condition(s) this trial covers.